Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Mirikizumab Autoinjector
DRUG
2 trials
Sponsors
Eli Lilly and Company
Conditions
Healthy
Phase 1
A Study of Mirikizumab in Healthy Participants
Completed
NCT04607733
Eli Lilly and Company
Healthy
Start: 2020-11-02
End: 2021-05-17
Updated: 2024-02-20
A Study to Compare Two Formulations of Mirikizumab (LY3074828) in Healthy Participants
Completed
NCT05069896
Eli Lilly and Company
Healthy
Start: 2021-10-05
End: 2022-06-22
Updated: 2025-03-04
Related Papers
Pharmacokinetic Bridging Between an Autoinjector and a Prefilled Syringe Following Subcutaneous Administration of Mirikizumab in Healthy Participants
Advances in Therapy
2025-09-03